Scholar Rock (SRRK)
NASDAQ: SRRK
· Real-Time Price · USD
32.15
-0.30 (-0.92%)
At close: Jun 16, 2025, 3:59 PM
32.13
-0.06%
After-hours: Jun 16, 2025, 06:00 PM EDT
-0.92% (1D)
Bid | 31 |
Market Cap | 3.05B |
Revenue (ttm) | n/a |
Net Income (ttm) | -264.16M |
EPS (ttm) | -2.55 |
PE Ratio (ttm) | -12.61 |
Forward PE | -21.76 |
Analyst | Buy |
Ask | 34.8 |
Volume | 756,815 |
Avg. Volume (20D) | 1,281,944 |
Open | 32.51 |
Previous Close | 32.45 |
Day's Range | 31.44 - 32.81 |
52-Week Range | 6.76 - 46.98 |
Beta | 0.30 |
About SRRK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SRRK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SRRK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-2.74%
SRRK stock has given up its prior gain. Scholar Ro...
Unlock content with
Pro Subscription
1 month ago
-2.74%
Scholar Rock Holding shares are trading higher following Q1 reported financial results.

2 weeks ago · businesswire.com
Scholar Rock to Present at the Jefferies Global Healthcare ConferenceCAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (...

1 month ago · seekingalpha.com
Scholar Rock Holding Corporation (SRRK) Q1 2025 Earnings Call TranscriptScholar Rock Holding Corporation (NASDAQ:SRRK ) Q1 2025 Earnings Conference Call May 14, 2025 8:15 AM ET Company Participants Rushmie Nofsinger - VP, Corporate Affairs and IR David Hallal - CEO Akshay...